Insider · CIK 0001742143
Nick Pizzie
Files at AXSM (Axsome Therapeutics, Inc.). First filing Feb 14, 2025, latest Feb 14, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXSM: Axsome Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Axsome Therapeutics, Inc. | $2.0M 15,000 shares | -28% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +9,516 | $0.00 | $0 | 9,516 | Feb 25, 2025 |
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +9,423 | $0.00 | $0 | 9,423 | Feb 25, 2025 |
| Feb 24, 2025 | AXSM Axsome Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +9,423 | $0.00 | $0 | 9,423 | Feb 25, 2025 |
| Feb 13, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +12,000 | $3.50 | $42k | 54,187 | Feb 14, 2025 |
| Feb 13, 2025 | AXSM Axsome Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -12,000 | $129.86 | $1.6M | 42,187 | Feb 14, 2025 |
| Feb 14, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,000 | $3.50 | $11k | 45,187 | Feb 14, 2025 |
| Feb 14, 2025 | AXSM Axsome Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,000 | $131.07 | $393k | 42,187 | Feb 14, 2025 |
| Feb 13, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $3.50 | $42k | 0 | Feb 14, 2025 |
| Feb 14, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,000 | $3.50 | $11k | 0 | Feb 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.